Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa
収録刊行物
-
- Journal of the American Academy of Dermatology
-
Journal of the American Academy of Dermatology 83 (2), 447-454, 2020-08
Elsevier BV